Construction and Identification of α-MHC Promoter-driven CREG Eukaryotic Expressive Plasmid

LUAN Bo,LI Jie,DUAN Yan,ZHANG Na,HUO Yu,LIANG Zhuo,YAN Cheng-hui,HAN Ya-ling
DOI: https://doi.org/10.13241/j.cnki.pmb.2011.19.009
2011-01-01
Abstract:Objective: To construct a eukaryotic expressive plasmid for cellular repressor of E1A-stimulated genes(CREG) driven by a cardiac specific promoter α-MHC and reported by green fluorescent protein,and then to observe its expression in mouse primary cardiomyocytes in vitro.Methods: CREG fragment was released from pcDNA3.1 myc-His/hCREG plasmid by BamH I and EcoR I digestion enzymes,and then was subcloned into pEGFP-N1 plasmid to construct pCREG-EGFP-N1 plasmid.The α-MHC promoter sequence was synthesized according to Genebank,and was attached with Ase I and Nhe I restrictive endonuclease sites at each side.The α-MHC promoter sequence was released from pUC57-α-MHC plasmid by Ase I and Nhe I digestion enzyme,and then replace cytomegalo virus(CMV) promoter of pCREG-EGFP-N1 plasmid to construct pα-MHC-EGFP-N1 plasmid.Then,the recombinant pα-MHC-CREG-EGFP-N1 plasmid was then transfected into mouse primary cardiomyocytes by liposome.The green fluorescent protein expression was observed by fluorescent microscopy and CREG expression was detected by Western blot.Results: pα-MHC-CREG-EGFP-N1 was identified by enzyme digestion and sequencing analysis.The results showed that length of the target genes which were inserted into the recombinant plasmid was correct.The strong expression of green fluorecent protein was observed by fluorecent microscopy,and the expression of CREG protein was detected by Western blot.These results confirmed that mouse primary cardiomyocytes were successfully transfected with plasmid.Conclusion: The pα-MHC-CREG-EGFP-N1 eukaryotic expressive plasmid was successfully constructed and the recombinant vector provides a powerful approach in investigating the function and regulation of CREG in cardiovascular diseases development and also in producing mouse cardiomyocyte specific hyper-expressive CREG transgenic mice.
What problem does this paper attempt to address?